$LGYV
LEGACY VENTURES INTERNATIONAL INC.

2024 Q2 Form 10-Q Financial Statement

#000149315224023785 Filed on June 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.77K $16.79K
YoY Change -35.85% 101.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.77K $16.79K
YoY Change -35.85% 101.32%
Operating Profit -$10.77K -$16.79K
YoY Change -35.87% 101.23%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.00
YoY Change
Pretax Income -$10.77K -$16.80K
YoY Change -35.89% 101.38%
Income Tax
% Of Pretax Income
Net Earnings -$10.77K -$16.80K
YoY Change -35.89% 101.38%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 50.32M shares 50.32M shares 50.32M shares
Diluted Shares Outstanding 50.32M shares 50.32M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $840.00 $360.00
YoY Change 133.33%
Cash & Equivalents $842.00 $842.00 $356.00
Short-Term Investments
Other Short-Term Assets $510.00 $510.00
YoY Change 0.0%
Inventory
Prepaid Expenses $509.00 $509.00
Receivables
Other Receivables
Total Short-Term Assets $1.350K $870.00
YoY Change 55.17%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.00 -$5.00
YoY Change -120.0%
TOTAL ASSETS
Total Short-Term Assets $1.350K $870.00
Total Long-Term Assets $1.00 -$5.00
Total Assets $842.00 $1.351K $865.00
YoY Change -61.5% 56.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.03K $12.21K
YoY Change 14.91% -87.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $91.45K $38.18K
YoY Change 139.52% -63.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $91.45K $38.18K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $137.7K $91.45K $38.18K
YoY Change 84.18% 139.53% -63.11%
SHAREHOLDERS EQUITY
Retained Earnings -$6.572M -$6.525M -$6.472M
YoY Change 0.99% 0.82%
Common Stock $5.032K $5.032K $5.032K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$136.9K -$90.10K -$37.31K
YoY Change
Total Liabilities & Shareholders Equity $842.00 $1.351K $865.00
YoY Change -61.5% 56.18%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$10.77K -$16.80K
YoY Change -35.89% 101.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$32.24K -$4.100K
YoY Change 686.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 32.25K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -32.24K -4.100K
Cash From Investing Activities
Cash From Financing Activities 32.25K 0.000
Net Change In Cash 10.00 -4.100K
YoY Change -100.24%
FREE CASH FLOW
Cash From Operating Activities -$32.24K -$4.100K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 LGYV Bank Charges And Other
BankChargesAndOther
usd
LGYV Bank Charges And Other
BankChargesAndOther
usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
509 usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q4 us-gaap Assets
Assets
1351 usd
CY2023Q2 us-gaap Assets
Assets
2187 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14031 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
11339 usd
us-gaap Professional Fees
ProfessionalFees
11000 usd
us-gaap Professional Fees
ProfessionalFees
19635 usd
CY2023Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5268 usd
CY2022Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5452 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6512 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6823 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1678 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
509 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-16791 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17512 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
842 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
38602 usd
CY2023Q4 us-gaap Liabilities
Liabilities
91446 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5032 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6429771 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6524898 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-90095 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1351 usd
CY2022Q4 LGYV Bank Charges And Other
BankChargesAndOther
-4 usd
LGYV Bank Charges And Other
BankChargesAndOther
-150 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-150 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10768 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16795 usd
us-gaap Net Income Loss
NetIncomeLoss
-17512 usd
us-gaap Net Income Loss
NetIncomeLoss
-26608 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50315064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50315064 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-10704 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9813 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37312 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-72583 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6744 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-79327 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-10768 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-90095 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-90095 usd
us-gaap Net Income Loss
NetIncomeLoss
-17512 usd
us-gaap Net Income Loss
NetIncomeLoss
-26608 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
509 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-24571 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8041 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10768 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-26458 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42083 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35158 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
41247 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
14497 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41247 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14497 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-836 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-20661 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1678 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21017 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
842 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
356 usd
CY2023Q4 LGYV Working Capital Deficit
WorkingCapitalDeficit
90095 usd
CY2023Q2 LGYV Working Capital Deficit
WorkingCapitalDeficit
72583 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6524898 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6507386 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50315064 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50315064 shares

Files In Submission

Name View Source Status
0001493152-24-023785-index-headers.html Edgar Link pending
0001493152-24-023785-index.html Edgar Link pending
0001493152-24-023785.txt Edgar Link pending
0001493152-24-023785-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lgyv-20231231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lgyv-20231231_cal.xml Edgar Link unprocessable
lgyv-20231231_def.xml Edgar Link unprocessable
lgyv-20231231_lab.xml Edgar Link unprocessable
lgyv-20231231_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable